Colfax (NYSE:CFX)‘s stock had its “buy” rating restated by research analysts at Seaport Global Securities in a research note issued to investors on Wednesday, February 7th. Seaport Global Securities also issued estimates for Colfax’s Q1 2018 earnings at $0.37 EPS, Q2 2018 earnings at $0.47 EPS, Q3 2018 earnings at $0.62 EPS, Q4 2018 earnings at $0.67 EPS, FY2018 earnings at $2.13 EPS, Q1 2019 earnings at $0.47 EPS, Q2 2019 earnings at $0.55 EPS, Q3 2019 earnings at $0.70 EPS, Q4 2019 earnings at $0.75 EPS and FY2019 earnings at $2.47 EPS.
Several other equities analysts also recently commented on the stock. Robert W. Baird cut their price target on shares of Colfax from $47.00 to $42.00 and set an “outperform” rating on the stock in a report on Wednesday, February 7th. Gabelli upgraded shares of Colfax from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th. They noted that the move was a valuation call. KeyCorp cut their price target on shares of Colfax from $46.00 to $44.00 and set an “overweight” rating on the stock in a report on Wednesday, February 7th. Stifel Nicolaus cut their price target on shares of Colfax from $48.00 to $40.00 and set a “buy” rating on the stock in a report on Wednesday, February 7th. Finally, Zacks Investment Research upgraded shares of Colfax from a “hold” rating to a “strong-buy” rating and set a $47.00 target price on the stock in a research note on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Colfax presently has a consensus rating of “Buy” and an average target price of $44.40.
Shares of Colfax (NYSE CFX) traded up $0.26 during midday trading on Wednesday, hitting $33.22. 1,132,737 shares of the stock traded hands, compared to its average volume of 933,469. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.80 and a quick ratio of 1.47. The stock has a market cap of $4,072.04, a PE ratio of 27.35, a price-to-earnings-growth ratio of 1.14 and a beta of 1.17. Colfax has a 52-week low of $31.50 and a 52-week high of $43.29.
Colfax (NYSE:CFX) last announced its earnings results on Tuesday, February 6th. The industrial products company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.01. The firm had revenue of $874.00 million for the quarter, compared to analysts’ expectations of $894.02 million. Colfax had a net margin of 4.28% and a return on equity of 6.11%. The business’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.46 EPS. equities analysts forecast that Colfax will post 2.11 EPS for the current fiscal year.
In other news, SVP A. Lynne Puckett sold 7,270 shares of the company’s stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $42.01, for a total value of $305,412.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Daniel A. Pryor sold 53,333 shares of the company’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $38.15, for a total transaction of $2,034,653.95. Following the completion of the sale, the executive vice president now directly owns 93,557 shares of the company’s stock, valued at approximately $3,569,199.55. The disclosure for this sale can be found here. 10.60% of the stock is owned by corporate insiders.
Several institutional investors and hedge funds have recently made changes to their positions in the company. M&T Bank Corp lifted its position in shares of Colfax by 0.7% in the 2nd quarter. M&T Bank Corp now owns 5,510 shares of the industrial products company’s stock worth $216,000 after purchasing an additional 41 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of Colfax by 7.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,688 shares of the industrial products company’s stock worth $145,000 after purchasing an additional 251 shares during the period. Eqis Capital Management Inc. lifted its position in shares of Colfax by 11.7% in the 3rd quarter. Eqis Capital Management Inc. now owns 13,531 shares of the industrial products company’s stock worth $563,000 after purchasing an additional 1,415 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Colfax by 49.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,264 shares of the industrial products company’s stock worth $209,000 after purchasing an additional 1,731 shares during the period. Finally, Pacer Advisors Inc. lifted its position in shares of Colfax by 11.6% in the 3rd quarter. Pacer Advisors Inc. now owns 17,630 shares of the industrial products company’s stock worth $734,000 after purchasing an additional 1,834 shares during the period. 75.82% of the stock is owned by hedge funds and other institutional investors.
WARNING: This article was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/02/15/seaport-global-securities-reiterates-buy-rating-for-colfax-cfx.html.
Colfax Company Profile
Colfax Corporation is an industrial manufacturing and engineering company. The Company provides air and gas handling, and fabrication technology products and services. The Company’s segments include Air and Gas handling, and Fabrication Technology. The Air and Gas Handling segment supplies a range of gas handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps and certain related products, as well as aftermarket services.
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.